{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:49:43Z","timestamp":1776476983562,"version":"3.51.2"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,18]]},"DOI":"10.7759\/cureus.45510","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T05:26:50Z","timestamp":1695101210000},"source":"Crossref","is-referenced-by-count":6,"title":["Biofilm's Impact on Inflammatory Bowel Diseases"],"prefix":"10.7759","author":[{"given":"Gopal S","family":"Palandurkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622934","article-title":"Role of the IL23\/IL17 pathway in Crohn\u2019s disease","volume":"12","author":"Schmitt H","year":"2021","unstructured":"Schmitt H, Neurath MF, Atreya R.  Role of the IL23\/IL17 pathway in Crohn\u2019s disease. Front Immunol. 2021, 12:622934. 10.3389\/fimmu.2021.622934","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan G","year":"2012","unstructured":"Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012, 72:2333-49. 10.2165\/11638120-000000000-00000","journal-title":"Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788168146","article-title":"The gut microbiota in inflammatory bowel disease","volume":"15","author":"Macfarlane GT","year":"2009","unstructured":"Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Curr Pharm Des. 2009, 15:1528-36. 10.2174\/138161209788168146","journal-title":"Curr Pharm Des"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2009.08.004","article-title":"Inflammatory bowel disease, gut bacteria and probiotic therapy","volume":"300","author":"Reiff C","year":"2010","unstructured":"Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol. 2010, 300:25-33. 10.1016\/j.ijmm.2009.08.004","journal-title":"Int J Med Microbiol"},{"key":"ref5","article-title":"Mucosal flora in Crohn's disease and ulcerative colitis - an overview","volume":"60","author":"Swidsinski A","year":"2009","unstructured":"Swidsinski A, Loening-Baucke V, Herber A. Mucosal flora in Crohn's disease and ulcerative colitis - an overview. J Physiol Pharmacol. 2009, 60:61-71.","journal-title":"J Physiol Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3380-3389.2005","article-title":"Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease","volume":"43","author":"Swidsinski A","year":"2005","unstructured":"Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol. 2005, 43:3380-9. 10.1128\/JCM.43.7.3380-3389.2005","journal-title":"J Clin Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2007.52","article-title":"Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum","volume":"1","author":"Baumgart M","year":"2007","unstructured":"Baumgart M, Dogan B, Rishniw M, et al.. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 2007, 1:403-18. 10.1038\/ismej.2007.52","journal-title":"ISME J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.046","article-title":"Recent insights into the genetics of inflammatory bowel disease","volume":"140","author":"Cho JH","year":"2011","unstructured":"Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology. 2011, 140:1704-12. 10.1053\/j.gastro.2011.02.046","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8133-2","article-title":"Crohn's disease: an immune deficiency state","volume":"38","author":"Marks DJ","year":"2010","unstructured":"Marks DJ, Rahman FZ, Sewell GW, Segal AW. Crohn's disease: an immune deficiency state. Clin Rev Allergy Immunol. 2010, 38:20-31. 10.1007\/s12016-009-8133-2","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley L","year":"2004","unstructured":"Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004, 2:95-108. 10.1038\/nrmicro821","journal-title":"Nat Rev Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-85657-7.00006-7","article-title":"Importance and Applications of Biofilm in Microbe-Assisted Bioremediation","author":"Gadkari J","year":"2022","unstructured":"Gadkari J, Bhattacharya S, Shrivastav A. Importance and Applications of Biofilm in Microbe-Assisted Bioremediation. In: Development in Wastewater Treatment Research and Processes. Elsevier, 2022. 153-73. 10.1016\/B978-0-323-85657-7.00006-7"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2018.08.009","article-title":"Bowel biofilms: tipping points between a healthy and compromised gut?","volume":"27","author":"Tytgat HL","year":"2019","unstructured":"Tytgat HL, Nobrega FL, van der Oost J, de Vos WM. Bowel biofilms: tipping points between a healthy and compromised gut?. Trends Microbiol. 2019, 27:17-25. 10.1016\/j.tim.2018.08.009","journal-title":"Trends Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2016.11.004","article-title":"Prevalence of apical periodontitis in patients with inflammatory bowel diseases: A retrospective clinical study","volume":"43","author":"Piras V","year":"2017","unstructured":"Piras V, Usai P, Mezzena S, Susnik M, Ideo F, Schirru E, Cotti E. Prevalence of apical periodontitis in patients with inflammatory bowel diseases: A retrospective clinical study. J Endod. 2017, 43:389-94. 10.1016\/j.joen.2016.11.004","journal-title":"J Endod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.12698","article-title":"Inflammatory bowel disease and oral health: systematic review and a meta-analysis","volume":"44","author":"Papageorgiou SN","year":"2017","unstructured":"Papageorgiou SN, Hagner M, Nogueira AV, Franke A, J\u00e4ger A, Deschner J. Inflammatory bowel disease and oral health: systematic review and a meta-analysis. J Clin Periodontol. 2017, 44:382-93. 10.1111\/jcpe.12698","journal-title":"J Clin Periodontol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends","volume":"17","author":"Benchimol EI","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011, 17:423-39. 10.1002\/ibd.21349","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-51","article-title":"The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis","volume":"12","author":"Soon IS","year":"2012","unstructured":"Soon IS, Molodecky NA, Rabi DM, Ghali WA, Barkema HW, Kaplan GG. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012, 12:51. 10.1186\/1471-230X-12-51","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.251.1.73","article-title":"Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer","volume":"251","author":"Crohn BB","year":"1984","unstructured":"Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. JAMA. 1984, 251:73-9. 10.1001\/jama.251.1.73","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198806000-00012","article-title":"Historical aspects of inflammatory bowel disease","volume":"10","author":"Kirsner JB","year":"1988","unstructured":"Kirsner JB. Historical aspects of inflammatory bowel disease. J Clin Gastroenterol. 1988, 10:286-97. 10.1097\/00004836-198806000-00012","journal-title":"J Clin Gastroenterol"},{"key":"ref19","article-title":"Increasing incidence of Crohn's disease in India: is it related to improved sanitation?","volume":"24","author":"Desai HG","year":"2005","unstructured":"Desai HG, Gupte PA. Increasing incidence of Crohn's disease in India: is it related to improved sanitation?. Indian J Gastroenterol. 2005, 24:23-4.","journal-title":"Indian J Gastroenterol"},{"key":"ref20","article-title":"Is Crohn's disease rare in India?","volume":"19","author":"Pai CG","year":"2000","unstructured":"Pai CG, Khandige GK. Is Crohn's disease rare in India?. Indian J Gastroenterol. 2000, 19:17-20.","journal-title":"Indian J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-017-0809-6","article-title":"Multi-center prospective survey of inflammatory bowel diseases in Kerala: more than 2000 cases","volume":"36","author":"Philip M","year":"2017","unstructured":"Philip M, Augustine P, Thomas V, et al.. Multi-center prospective survey of inflammatory bowel diseases in Kerala: more than 2000 cases. Indian J Gastroenterol. 2017, 36:459-67. 10.1007\/s12664-017-0809-6","journal-title":"Indian J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2016.11.010","article-title":"Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms","volume":"47","author":"Beatty JK","year":"2017","unstructured":"Beatty JK, Akierman SV, Motta JP, et al.. Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms. Int J Parasitol. 2017, 47:311-26. 10.1016\/j.ijpara.2016.11.010","journal-title":"Int J Parasitol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407460101","article-title":"Self-generated diversity produces \"insurance effects\" in biofilm communities","volume":"101","author":"Boles BR","year":"2004","unstructured":"Boles BR, Thoendel M, Singh PK. Self-generated diversity produces \"insurance effects\" in biofilm communities. Proc Natl Acad Sci U S A. 2004, 101:16630-5. 10.1073\/pnas.0407460101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2008.0110","article-title":"Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis","volume":"5","author":"Atalla H","year":"2008","unstructured":"Atalla H, Gyles C, Jacob CL, Moisan H, Malouin F, Mallard B. Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog Dis. 2008, 5:785-99. 10.1089\/fpd.2008.0110","journal-title":"Foodborne Pathog Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/17453670710013843","article-title":"The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics","volume":"78","author":"Neut D","year":"2007","unstructured":"Neut D, van der Mei HC, Bulstra SK, Busscher HJ. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop. 2007, 78:299-308. 10.1080\/17453670710013843","journal-title":"Acta Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00520-10","article-title":"Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus","volume":"48","author":"G\u00f3mez-Gonz\u00e1lez C","year":"2010","unstructured":"G\u00f3mez-Gonz\u00e1lez C, Acosta J, Villa J, et al.. Clinical and molecular characteristics of infections with CO2-dependent small-colony variants of Staphylococcus aureus. J Clin Microbiol. 2010, 48:2878-84. 10.1128\/JCM.00520-10","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg PB","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN, et al.. Diversity of the human intestinal microbial flora. Science. 2005, 308:1635-8. 10.1126\/science.1110591","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank DN","year":"2007","unstructured":"Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007, 104:13780-5. 10.1073\/pnas.0706625104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/00365520801935434","article-title":"Fungi and inflammatory bowel diseases: alterations of composition and diversity","volume":"43","author":"Ott SJ","year":"2008","unstructured":"Ott SJ, K\u00fchbacher T, Musfeldt M, et al.. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol. 2008, 43:831-41. 10.1080\/00365520801935434","journal-title":"Scand J Gastroenterol"},{"key":"ref30","article-title":"Dysbiosis as a prerequisite for IBD","volume":"53","author":"Tamboli CP","year":"2004","unstructured":"Tamboli CP, Neut C, Desreumaux P, Colombel JF. Dysbiosis as a prerequisite for IBD. Gut. 2004, 53:1057.","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.9.5529-5537.2001","article-title":"Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death","volume":"69","author":"Glasser AL","year":"2001","unstructured":"Glasser AL, Boudeau J, Barnich N, Perruchot MH, Colombel JF, Darfeuille-Michaud A. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001, 69:5529-37. 10.1128\/IAI.69.9.5529-5537.2001","journal-title":"Infect Immun"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.207456","article-title":"Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion","volume":"59","author":"Rolhion N","year":"2010","unstructured":"Rolhion N, Barnich N, Bringer MA, et al.. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut. 2010, 59:1355-62. 10.1136\/gut.2010.207456","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46498-0","article-title":"The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients","volume":"55","author":"Bibiloni R","year":"2006","unstructured":"Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006, 55:1141-9. 10.1099\/jmm.0.46498-0","journal-title":"J Med Microbiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v6.22962","article-title":"Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases","volume":"6","author":"Nibali L","year":"2014","unstructured":"Nibali L, Henderson B, Sadiq ST, Donos N. Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases. J Oral Microbiol. 2014, 6:10.3402\/jom.v6.22962","journal-title":"J Oral Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5497\/wjp.v8.i3.26","article-title":"Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases","volume":"8","author":"Chandra N","year":"2019","unstructured":"Chandra N, Srivastava A, Kumar S. Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases. World J Pharmacol. 2019, 8:26-40. 10.5497\/wjp.v8.i3.26","journal-title":"World J Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411374200","article-title":"A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence","volume":"279","author":"Vuong C","year":"2004","unstructured":"Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem. 2004, 279:54881-6. 10.1074\/jbc.M411374200","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/jor.24019","article-title":"Periprosthetic bacterial biofilm and quorum sensing","volume":"36","author":"Mooney JA","year":"2018","unstructured":"Mooney JA, Pridgen EM, Manasherob R, et al.. Periprosthetic bacterial biofilm and quorum sensing. J Orthop Res. 2018, 36:2331-9. 10.1002\/jor.24019","journal-title":"J Orthop Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcma.2017.07.012","article-title":"Bacterial biofilm and associated infections","volume":"81","author":"Jamal M","year":"2018","unstructured":"Jamal M, Ahmad W, Andleeb S, et al.. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018, 81:7-11. 10.1016\/j.jcma.2017.07.012","journal-title":"J Chin Med Assoc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jam.15049","article-title":"Diagnosis of biofilm infections: current methods used, challenges and perspectives for the future","volume":"131","author":"Silva NB","year":"2021","unstructured":"Silva NB, Marques LA, R\u00f6der DD. Diagnosis of biofilm infections: current methods used, challenges and perspectives for the future. J Appl Microbiol. 2021, 131:2148-60. 10.1111\/jam.15049","journal-title":"J Appl Microbiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2017.1313372","article-title":"Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action","volume":"9","author":"Roy R","year":"2018","unstructured":"Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018, 9:522-54. 10.1080\/21505594.2017.1313372","journal-title":"Virulence"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/jof3020022","article-title":"Fungal biofilms and polymicrobial diseases","volume":"3","author":"Costa-Orlandi CB","year":"2017","unstructured":"Costa-Orlandi CB, Sardi JC, Pitangui NS, et al.. Fungal biofilms and polymicrobial diseases. J Fungi (Basel). 2017, 3:10.3390\/jof3020022","journal-title":"J Fungi (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2016.03.002","article-title":"Confocal microscopy imaging of the biofilm matrix","volume":"138","author":"Schlafer S","year":"2017","unstructured":"Schlafer S, Meyer RL. Confocal microscopy imaging of the biofilm matrix. J Microbiol Methods. 2017, 138:50-9. 10.1016\/j.mimet.2016.03.002","journal-title":"J Microbiol Methods"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/srep25889","article-title":"Imaging of bacterial multicellular behaviour in biofilms in liquid by atmospheric scanning electron microscopy","volume":"6","author":"Sugimoto S","year":"2016","unstructured":"Sugimoto S, Okuda K, Miyakawa R, et al.. Imaging of bacterial multicellular behaviour in biofilms in liquid by atmospheric scanning electron microscopy. Sci Rep. 2016, 6:25889. 10.1038\/srep25889","journal-title":"Sci Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2016.1169990","article-title":"Fluorescence in situ hybridization (FISH) in the microbiological diagnostic routine laboratory: a review","volume":"43","author":"Frickmann H","year":"2017","unstructured":"Frickmann H, Zautner AE, Moter A, Kikhney J, Hagen RM, Stender H, Poppert S. Fluorescence in situ hybridization (FISH) in the microbiological diagnostic routine laboratory: a review. Crit Rev Microbiol. 2017, 43:263-93. 10.3109\/1040841X.2016.1169990","journal-title":"Crit Rev Microbiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(77)90034-8","article-title":"A semiquantitative culture method for identification of catheter-related infection in the burn patient","volume":"22","author":"Maki DG","year":"1977","unstructured":"Maki DG, Jarrett F, Sarafin HW. A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res. 1977, 22:513-20. 10.1016\/0022-4804(77)90034-8","journal-title":"J Surg Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","article-title":"Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci","volume":"115","author":"Stepanovi\u0107 S","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, Di Bonaventura G, Djuki\u0107 S, Cirkovi\u0107 I, Ruzicka F. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007, 115:891-9. 10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.13017","article-title":"Biofilm formation of Staphylococcus aureus on various surfaces and their resistance to chlorine sanitizer","volume":"80","author":"Lee JS","year":"2015","unstructured":"Lee JS, Bae YM, Lee SY, Lee SY. Biofilm formation of Staphylococcus aureus on various surfaces and their resistance to chlorine sanitizer. J Food Sci. 2015, 80:M2279-86. 10.1111\/1750-3841.13017","journal-title":"J Food Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2018.246","article-title":"Detection of biofilm producing staphylococci among different clinical isolates and its relation to methicillin susceptibility","volume":"6","author":"Abdel Halim RM","year":"2018","unstructured":"Abdel Halim RM, Kassem NN, Mahmoud BS. Detection of biofilm producing staphylococci among different clinical isolates and its relation to methicillin susceptibility. Open Access Maced J Med Sci. 2018, 6:1335-41. 10.3889\/oamjms.2018.246","journal-title":"Open Access Maced J Med Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-015-0134-3","article-title":"Prevalence of virulence genes of biofilm producing strains of Staphylococcus epidermidis isolated from clinical samples in Iran","volume":"5","author":"Solati SM","year":"2015","unstructured":"Solati SM, Tajbakhsh E, Khamesipour F, Gugnani HC. Prevalence of virulence genes of biofilm producing strains of Staphylococcus epidermidis isolated from clinical samples in Iran. AMB Express. 2015, 5:134. 10.1186\/s13568-015-0134-3","journal-title":"AMB Express"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.6.996-1006.1985","article-title":"Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices","volume":"22","author":"Christensen GD","year":"1985","unstructured":"Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985, 22:996-1006. 10.1128\/jcm.22.6.996-1006.1985","journal-title":"J Clin Microbiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1039\/c8an01488d","article-title":"A review of methods for the detection of pathogenic microorganisms","volume":"144","author":"Rajapaksha P","year":"2019","unstructured":"Rajapaksha P, Elbourne A, Gangadoo S, Brown R, Cozzolino D, Chapman J. A review of methods for the detection of pathogenic microorganisms. Analyst. 2019, 144:396-411. 10.1039\/c8an01488d","journal-title":"Analyst"},{"key":"ref52","article-title":"Determining the biofilm forming gene profile of Staphylococcus aureus clinical isolates via multiplex colony PCR method","volume":"7","author":"Shahmoradi M","year":"2019","unstructured":"Shahmoradi M, Faridifar P, Shapouri R, Mousavi SF, Ezzedin M, Mirzaei B. Determining the biofilm forming gene profile of Staphylococcus aureus clinical isolates via multiplex colony PCR method. Rep Biochem Mol Biol. 2019, 7:181-8.","journal-title":"Rep Biochem Mol Biol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1117\/1.2793736","article-title":"Optical coherence tomography: a review of clinical development from bench to bedside","volume":"12","author":"Zysk AM","year":"2007","unstructured":"Zysk AM, Nguyen FT, Oldenburg AL, Marks DL, Boppart SA. Optical coherence tomography: a review of clinical development from bench to bedside. J Biomed Opt. 2007, 12:051403. 10.1117\/1.2793736","journal-title":"J Biomed Opt"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.12.076","article-title":"Novel method for non-invasive induction of a middle-ear biofilm in the rat","volume":"29","author":"Chaney EJ","year":"2011","unstructured":"Chaney EJ, Nguyen CT, Boppart SA. Novel method for non-invasive induction of a middle-ear biofilm in the rat. Vaccine. 2011, 29:1628-33. 10.1016\/j.vaccine.2010.12.076","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232214259","article-title":"Biofilms and benign colonic diseases","volume":"23","author":"Songtanin B","year":"2022","unstructured":"Songtanin B, Peterson CJ, Molehin AJ, Nugent K. Biofilms and benign colonic diseases. Int J Mol Sci. 2022, 23:10.3390\/ijms232214259","journal-title":"Int J Mol Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.55.1.165","article-title":"Quorum sensing in bacteria","volume":"55","author":"Miller MB","year":"2001","unstructured":"Miller MB, Bassler BL. Quorum sensing in bacteria. Annu Rev Microbiol. 2001, 55:165-99. 10.1146\/annurev.micro.55.1.165","journal-title":"Annu Rev Microbiol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2003.03688.x","article-title":"Quorum sensing controls biofilm formation in Vibrio cholerae","volume":"50","author":"Hammer BK","year":"2003","unstructured":"Hammer BK, Bassler BL. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol. 2003, 50:101-4. 10.1046\/j.1365-2958.2003.03688.x","journal-title":"Mol Microbiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i23.3562","article-title":"Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease","volume":"19","author":"Goli\u0144ska E","year":"2013","unstructured":"Goli\u0144ska E, Tomusiak A, Gosiewski T, et al.. Virulence factors of Enterococcus strains isolated from patients with inflammatory bowel disease. World J Gastroenterol. 2013, 19:3562-72. 10.3748\/wjg.v19.i23.3562","journal-title":"World J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos FS","year":"2005","unstructured":"Velayos FS, Terdiman JP, Walsh JM. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol. 2005, 100:1345-53. 10.1111\/j.1572-0241.2005.41442.x","journal-title":"Am J Gastroenterol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008870.pub2","article-title":"Aminosalicylates for induction of remission or response in Crohn's disease","volume":"7","author":"Lim WC","year":"2016","unstructured":"Lim WC, Wang Y, MacDonald JK, Hanauer S. Aminosalicylates for induction of remission or response in Crohn's disease. Cochrane Database Syst Rev. 2016, 7:CD008870. 10.1002\/14651858.CD008870.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer SB","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, et al.. Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial. Lancet. 2002, 359:1541-9. 10.1016\/s0140-6736(02)08512-4","journal-title":"Lancet"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0193-2","article-title":"Infliximab biosimilar (CT-P13; Infliximab-dyyb): a review in autoimmune inflammatory diseases","volume":"30","author":"Blair HA","year":"2016","unstructured":"Blair HA, Deeks ED. Infliximab biosimilar (CT-P13; Infliximab-dyyb): a review in autoimmune inflammatory diseases. BioDrugs. 2016, 30:469-80. 10.1007\/s40259-016-0193-2","journal-title":"BioDrugs"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.052","article-title":"Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis","volume":"146","author":"Panaccione R","year":"2014","unstructured":"Panaccione R, Ghosh S, Middleton S, et al.. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis. Gastroenterology. 2014, 146:392-400.e3. 10.1053\/j.gastro.2013.10.052","journal-title":"Gastroenterology"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904492","article-title":"Infliximab, azathioprine, or combination therapy for Crohn's disease","volume":"362","author":"Colombel JF","year":"2010","unstructured":"Colombel JF, Sandborn WJ, Reinisch W, et al.. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010, 362:1383-95. 10.1056\/NEJMoa0904492","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006013422202","article-title":"A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators","volume":"342","author":"Feagan BG","year":"2000","unstructured":"Feagan BG, Fedorak RN, Irvine EJ, et al.. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000, 342:1627-32. 10.1056\/NEJM200006013422202","journal-title":"N Engl J Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2016.0032","article-title":"Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis","volume":"29","author":"Feuerstein JD","year":"2016","unstructured":"Feuerstein JD, Akbari M, Tapper EB, Cheifetz AS. Systematic review and meta-analysis of third-line salvage therapy with infliximab or cyclosporine in severe ulcerative colitis. Ann Gastroenterol. 2016, 29:341-7. 10.20524\/aog.2016.0032","journal-title":"Ann Gastroenterol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/s0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda S","year":"2000","unstructured":"Matsuda S, Koyasu S. Mechanisms of action of cyclosporine. Immunopharmacology. 2000, 47:119-25. 10.1016\/s0162-3109(00)00192-2","journal-title":"Immunopharmacology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00256.2015","article-title":"Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis","volume":"309","author":"Nighot P","year":"2015","unstructured":"Nighot P, Al-Sadi R, Rawat M, Guo S, Watterson DM, Ma T. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis. Am J Physiol Gastrointest Liver Physiol. 2015, 309:G988-97. 10.1152\/ajpgi.00256.2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/643645","article-title":"Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases","volume":"2014","author":"Matusiewicz M","year":"2014","unstructured":"Matusiewicz M, Neubauer K, Mierzchala-Pasierb M, Gamian A, Krzystek-Korpacka M. Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseases. Dis Markers. 2014, 2014:643645. 10.1155\/2014\/643645","journal-title":"Dis Markers"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.09.005","article-title":"Rectal delivery of a DNAzyme that specifically blocks the transcription factor GATA3 and reduces colitis in mice","volume":"152","author":"Popp V","year":"2017","unstructured":"Popp V, Gerlach K, Mott S, et al.. Rectal delivery of a DNAzyme that specifically blocks the transcription factor GATA3 and reduces colitis in mice. Gastroenterology. 2017, 152:176-92.e5. 10.1053\/j.gastro.2016.09.005","journal-title":"Gastroenterology"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4046","article-title":"Transient inhibition of ROR-\u03b3t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells","volume":"22","author":"Withers DR","year":"2016","unstructured":"Withers DR, Hepworth MR, Wang X, et al.. Transient inhibition of ROR-\u03b3t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat Med. 2016, 22:319-23. 10.1038\/nm.4046","journal-title":"Nat Med"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.079434","article-title":"A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease","volume":"55","author":"Reinisch W","year":"2006","unstructured":"Reinisch W, Hommes DW, Van Assche G, et al.. A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease. Gut. 2006, 55:1138-44. 10.1136\/gut.2005.079434","journal-title":"Gut"},{"key":"ref73","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.158.5.2099","article-title":"Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells","volume":"158","author":"Picarella D","year":"1997","unstructured":"Picarella D, Hurlbut P, Rottman J, Shi X, Butcher E, Ringler DJ. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol. 1997, 158:2099-106.","journal-title":"J Immunol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116575","article-title":"Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody","volume":"92","author":"Podolsky DK","year":"1993","unstructured":"Podolsky DK, Lobb R, King N, Benjamin CD, Pepinsky B, Sehgal P, deBeaumont M. Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest. 1993, 92:372-80. 10.1172\/JCI116575","journal-title":"J Clin Invest"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn's disease","volume":"348","author":"Ghosh S","year":"2003","unstructured":"Ghosh S, Goldin E, Gordon FH, et al.. Natalizumab for active Crohn's disease. N Engl J Med. 2003, 348:24-32. 10.1056\/NEJMoa020732","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01144-08","article-title":"F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917","volume":"75","author":"Lasaro MA","year":"2009","unstructured":"Lasaro MA, Salinger N, Zhang J, Wang Y, Zhong Z, Goulian M, Zhu J. F1C fimbriae play an important role in biofilm formation and intestinal colonization by the Escherichia coli commensal strain Nissle 1917. Appl Environ Microbiol. 2009, 75:246-51. 10.1128\/AEM.01144-08","journal-title":"Appl Environ Microbiol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i24.5505","article-title":"Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update","volume":"22","author":"Scaldaferri F","year":"2016","unstructured":"Scaldaferri F, Gerardi V, Mangiola F, et al.. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J Gastroenterol. 2016, 22:5505-11. 10.3748\/wjg.v22.i24.5505","journal-title":"World J Gastroenterol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0337-1","article-title":"Fecal microbiota transplantation: indications, methods, evidence, and future directions","volume":"15","author":"Borody TJ","year":"2013","unstructured":"Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013, 15:337. 10.1007\/s11894-013-0337-1","journal-title":"Curr Gastroenterol Rep"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.004","article-title":"From stool transplants to next-generation microbiota therapeutics","volume":"146","author":"Petrof EO","year":"2014","unstructured":"Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology. 2014, 146:1573-82. 10.1053\/j.gastro.2014.01.004","journal-title":"Gastroenterology"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000000449","article-title":"Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease","volume":"59","author":"Cohen SA","year":"2014","unstructured":"Cohen SA, Gold BD, Oliva S, et al.. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2014, 59:516-21. 10.1097\/MPG.0000000000000449","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.035287","article-title":"Diet and relapsing ulcerative colitis: take off the meat?","volume":"53","author":"Tilg H","year":"2004","unstructured":"Tilg H, Kaser A. Diet and relapsing ulcerative colitis: take off the meat?. Gut. 2004, 53:1399-401. 10.1136\/gut.2003.035287","journal-title":"Gut"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.12.006","article-title":"The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy","volume":"149","author":"Cammarota G","year":"2015","unstructured":"Cammarota G, Ianiro G, Cianci R, Bibb\u00f2 S, Gasbarrini A, Curr\u00f2 D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther. 2015, 149:191-212. 10.1016\/j.pharmthera.2014.12.006","journal-title":"Pharmacol Ther"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1027463","article-title":"Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study","volume":"46","author":"Henker J","year":"2008","unstructured":"Henker J, M\u00fcller S, Laass MW, Schreiner A, Schulze J. Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol. 2008, 46:874-5. 10.1055\/s-2008-1027463","journal-title":"Z Gastroenterol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1159\/000465522","article-title":"Epidemiology of inflammatory bowel disease in India: the great shift east","volume":"2","author":"Kedia S","year":"2017","unstructured":"Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the great shift east. Inflamm Intest Dis. 2017, 2:102-15. 10.1159\/000465522","journal-title":"Inflamm Intest Dis"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i36.8123","article-title":"Inflammatory bowel disease in India - past, present and future","volume":"22","author":"Ray G","year":"2016","unstructured":"Ray G. Inflammatory bowel disease in India - past, present and future. World J Gastroenterol. 2016, 22:8123-36. 10.3748\/wjg.v22.i36.8123","journal-title":"World J Gastroenterol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01360-10","article-title":"Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India","volume":"48","author":"Verma R","year":"2010","unstructured":"Verma R, Verma AK, Ahuja V, Paul J. Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India. J Clin Microbiol. 2010, 48:4279-82. 10.1128\/JCM.01360-10","journal-title":"J Clin Microbiol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802556809","article-title":"High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country","volume":"44","author":"Banerjee D","year":"2009","unstructured":"Banerjee D, Deb R, Dar L, et al.. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scand J Gastroenterol. 2009, 44:325-31. 10.1080\/00365520802556809","journal-title":"Scand J Gastroenterol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5854285","article-title":"Ulcerative colitis and its association with salmonella species","volume":"2016","author":"Tripathi MK","year":"2016","unstructured":"Tripathi MK, Pratap CB, Dixit VK, Singh TB, Shukla SK, Jain AK, Nath G. Ulcerative colitis and its association with salmonella species. Interdiscip Perspect Infect Dis. 2016, 2016:5854285. 10.1155\/2016\/5854285","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1080\/16512235.2017.1322447","article-title":"Gut microbial diversity in health and disease: experience of healthy Indian subjects, and colon carcinoma and inflammatory bowel disease patients","volume":"28","author":"Bamola VD","year":"2017","unstructured":"Bamola VD, Ghosh A, Kapardar RK, Lal B, Cheema S, Sarma P, Chaudhry R. Gut microbial diversity in health and disease: experience of healthy Indian subjects, and colon carcinoma and inflammatory bowel disease patients. Microb Ecol Health Dis. 2017, 28:1322447. 10.1080\/16512235.2017.1322447","journal-title":"Microb Ecol Health Dis"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-012-0302-1","article-title":"Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis","volume":"32","author":"Iyer VH","year":"2013","unstructured":"Iyer VH, Augustine J, Pulimood AB, Ajjampur SS, Ramakrishna BS. Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis. Indian J Gastroenterol. 2013, 32:115-8. 10.1007\/s12664-012-0302-1","journal-title":"Indian J Gastroenterol"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.107786","article-title":"Adherent Escherichia coli in colorectal mucosal biopsies: a histological and ultrastructural evaluation","volume":"55","author":"Patra S","year":"2012","unstructured":"Patra S, Samal SC, Kang G, Pulimood A, Mathan M, Ramakrishna BS. Adherent Escherichia coli in colorectal mucosal biopsies: a histological and ultrastructural evaluation. Indian J Pathol Microbiol. 2012, 55:485-9. 10.4103\/0377-4929.107786","journal-title":"Indian J Pathol Microbiol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1590\/S1517-83822012000200050","article-title":"Expression of virulence genes by Listeria monocytogenes J0161 in natural environment","volume":"43","author":"Tirumalai PS","year":"2012","unstructured":"Tirumalai PS, Prakash S. Expression of virulence genes by Listeria monocytogenes J0161 in natural environment. Braz J Microbiol. 2012, 43:834-43. 10.1590\/S1517-83822012000200050","journal-title":"Braz J Microbiol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-016-0591-7","article-title":"Antibacterial effects of Lactobacillus isolates of curd and human milk origin against food-borne and human pathogens","volume":"7","author":"Sharma C","year":"2017","unstructured":"Sharma C, Singh BP, Thakur N, Gulati S, Gupta S, Mishra SK, Panwar H. Antibacterial effects of Lactobacillus isolates of curd and human milk origin against food-borne and human pathogens. 3 Biotech. 2017, 7:31. 10.1007\/s13205-016-0591-7","journal-title":"3 Biotech"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00120","article-title":"Anti-biofilm properties of the fecal probiotic Lactobacilli against Vibrio spp","volume":"8","author":"Kaur S","year":"2018","unstructured":"Kaur S, Sharma P, Kalia N, Singh J, Kaur S. Anti-biofilm properties of the fecal probiotic Lactobacilli against Vibrio spp. Front Cell Infect Microbiol. 2018, 8:120. 10.3389\/fcimb.2018.00120","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183491-biofilms-impact-on-inflammatory-bowel-diseases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:20Z","timestamp":1707508160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183491-biofilms-impact-on-inflammatory-bowel-diseases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,18]]},"references-count":94,"URL":"https:\/\/doi.org\/10.7759\/cureus.45510","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,18]]}}}